Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02608463 · ClinicalTrials.gov registry record · NA
Neuropathic Pain in Pregnancy
A NA study, sponsored by University of Arkansas.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02608463: Completed NA study, sponsored by University of Arkansas.
NCT02608463 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02608463, a NA study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This will be the first study to investigate the use of rTMS in the treatment of neuropathic pain in pregnancy. This study will enroll 60 pregnant subjects, age 18-45. All participants will receive treatment as usual. Subjects diagnosed with neuropathic pain will be offered rTMS as a treatment option.
Primary Outcome
100 mm line scale that is subject administered to subjectively rate current pain symptoms. The subject will be instructed to draw a single vertical line that best describes current state. The total score ranges from 0-100 with higher numbers indicating worse outcomes. The VAS will be administered at every subject visit.
Interventions
- BEHAVIORAL painDETECT Questionnaire
- BEHAVIORAL Pain Catastrophizing Scale
- BEHAVIORAL Pain Intensity Scale, Pain Interference Scale, Pain Behavior Scale
- BEHAVIORAL Beck Depression Inventory
- BEHAVIORAL Visual Analogue Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2019-04-19 |
| Phase | NA |
What the finished NCT02608463 record still lists
NCT02608463 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which painDETECT Questionnaire is the first listed.
NCT02608463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02608463 about?
NCT02608463 is a clinical study titled "Neuropathic Pain in Pregnancy". This will be the first study to investigate the use of rTMS in the treatment of neuropathic pain in pregnancy. This study will enroll 60 pregnant subjects, age 18-45. All participants will receive treatment as usual. Subjects diagnosed with neuropathic pain will be offered rTMS as a treatment option...
What is the current status of trial NCT02608463?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-01-01. Estimated completion is 2019-04-19.
What interventions are being tested in trial NCT02608463?
The interventions under investigation include: painDETECT Questionnaire (BEHAVIORAL), Pain Catastrophizing Scale (BEHAVIORAL), Pain Intensity Scale, Pain Interference Scale, Pain Behavior Scale (BEHAVIORAL), Beck Depression Inventory (BEHAVIORAL), Visual Analogue Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT02608463?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02608463's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI